Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy

Jessica R. Mader, Zachary T. Resch, Gary R. McLean, Jakob H. Mikkelsen, Claus Oxvig, Ronald J Marler, Cheryl A Conover

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We investigated pregnancy-associated plasma protein-A (PAPP-A) in diabetic nephropathy. Normal human kidney showed specific staining for PAPP-A in glomeruli, and this staining was markedly increased in diabetic kidney. To assess the possible contribution of PAPP-A in the development of diabetic nephropathy, we induced diabetes with streptozotocin in14-month-old WT and Papp-A knockout (KO) mice. Renal histopathology was evaluated after 4 months of stable hyperglycemia. Kidneys from diabetic WT mice showed multiple abnormalities including thickening of Bowman's capsule (100% of mice), increased glomerular size (80% of mice), tubule dilation (80% of mice), and mononuclear cell infiltration (90% of mice). Kidneys of age-matched non-diabetic WT mice had similar evidence of tubule dilation and mononuclear cell infiltration to those of diabetic WT mice, indicating that these changes were predominantly age-related. However, thickened Bowman's capsule and increased glomerular size appeared specific for the experimental diabetes. Kidneys from diabetic Papp-A KO mice had significantly reduced or no evidence of changes in Bowman's capsule thickening and glomerular size. There was also a shift to larger mesangial area and increased macrophage staining in diabetic WT mice compared with Papp-A KO mice. In summary, elevatedPAPP-A expression in glomeruli is associated with diabetic nephropathy in humans and absence of PAPP-A is associated with resistance to the development of indicators of diabeticnephropathy in mice. These data suggest PAPP-A as a potential therapeutic target for diabetic nephropathy.

Original languageEnglish (US)
Pages (from-to)51-58
Number of pages8
JournalJournal of Endocrinology
Volume219
Issue number1
DOIs
StatePublished - 2013

Fingerprint

Pregnancy-Associated Plasma Protein-A
Diabetic Nephropathies
Bowman Capsule
Kidney
Knockout Mice
Staining and Labeling
Dilatation
Multiple Abnormalities
Experimental Diabetes Mellitus
Hyperglycemia
Macrophages

Keywords

  • Bowman's capsule
  • Diabetes
  • Kidney
  • Pregnancy-associated plasma protein-A

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Mader, J. R., Resch, Z. T., McLean, G. R., Mikkelsen, J. H., Oxvig, C., Marler, R. J., & Conover, C. A. (2013). Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy. Journal of Endocrinology, 219(1), 51-58. https://doi.org/10.1530/JOE-13-0167

Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy. / Mader, Jessica R.; Resch, Zachary T.; McLean, Gary R.; Mikkelsen, Jakob H.; Oxvig, Claus; Marler, Ronald J; Conover, Cheryl A.

In: Journal of Endocrinology, Vol. 219, No. 1, 2013, p. 51-58.

Research output: Contribution to journalArticle

Mader, JR, Resch, ZT, McLean, GR, Mikkelsen, JH, Oxvig, C, Marler, RJ & Conover, CA 2013, 'Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy', Journal of Endocrinology, vol. 219, no. 1, pp. 51-58. https://doi.org/10.1530/JOE-13-0167
Mader, Jessica R. ; Resch, Zachary T. ; McLean, Gary R. ; Mikkelsen, Jakob H. ; Oxvig, Claus ; Marler, Ronald J ; Conover, Cheryl A. / Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy. In: Journal of Endocrinology. 2013 ; Vol. 219, No. 1. pp. 51-58.
@article{680990d7550e45c89a173466b015a826,
title = "Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy",
abstract = "We investigated pregnancy-associated plasma protein-A (PAPP-A) in diabetic nephropathy. Normal human kidney showed specific staining for PAPP-A in glomeruli, and this staining was markedly increased in diabetic kidney. To assess the possible contribution of PAPP-A in the development of diabetic nephropathy, we induced diabetes with streptozotocin in14-month-old WT and Papp-A knockout (KO) mice. Renal histopathology was evaluated after 4 months of stable hyperglycemia. Kidneys from diabetic WT mice showed multiple abnormalities including thickening of Bowman's capsule (100{\%} of mice), increased glomerular size (80{\%} of mice), tubule dilation (80{\%} of mice), and mononuclear cell infiltration (90{\%} of mice). Kidneys of age-matched non-diabetic WT mice had similar evidence of tubule dilation and mononuclear cell infiltration to those of diabetic WT mice, indicating that these changes were predominantly age-related. However, thickened Bowman's capsule and increased glomerular size appeared specific for the experimental diabetes. Kidneys from diabetic Papp-A KO mice had significantly reduced or no evidence of changes in Bowman's capsule thickening and glomerular size. There was also a shift to larger mesangial area and increased macrophage staining in diabetic WT mice compared with Papp-A KO mice. In summary, elevatedPAPP-A expression in glomeruli is associated with diabetic nephropathy in humans and absence of PAPP-A is associated with resistance to the development of indicators of diabeticnephropathy in mice. These data suggest PAPP-A as a potential therapeutic target for diabetic nephropathy.",
keywords = "Bowman's capsule, Diabetes, Kidney, Pregnancy-associated plasma protein-A",
author = "Mader, {Jessica R.} and Resch, {Zachary T.} and McLean, {Gary R.} and Mikkelsen, {Jakob H.} and Claus Oxvig and Marler, {Ronald J} and Conover, {Cheryl A}",
year = "2013",
doi = "10.1530/JOE-13-0167",
language = "English (US)",
volume = "219",
pages = "51--58",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",
number = "1",

}

TY - JOUR

T1 - Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy

AU - Mader, Jessica R.

AU - Resch, Zachary T.

AU - McLean, Gary R.

AU - Mikkelsen, Jakob H.

AU - Oxvig, Claus

AU - Marler, Ronald J

AU - Conover, Cheryl A

PY - 2013

Y1 - 2013

N2 - We investigated pregnancy-associated plasma protein-A (PAPP-A) in diabetic nephropathy. Normal human kidney showed specific staining for PAPP-A in glomeruli, and this staining was markedly increased in diabetic kidney. To assess the possible contribution of PAPP-A in the development of diabetic nephropathy, we induced diabetes with streptozotocin in14-month-old WT and Papp-A knockout (KO) mice. Renal histopathology was evaluated after 4 months of stable hyperglycemia. Kidneys from diabetic WT mice showed multiple abnormalities including thickening of Bowman's capsule (100% of mice), increased glomerular size (80% of mice), tubule dilation (80% of mice), and mononuclear cell infiltration (90% of mice). Kidneys of age-matched non-diabetic WT mice had similar evidence of tubule dilation and mononuclear cell infiltration to those of diabetic WT mice, indicating that these changes were predominantly age-related. However, thickened Bowman's capsule and increased glomerular size appeared specific for the experimental diabetes. Kidneys from diabetic Papp-A KO mice had significantly reduced or no evidence of changes in Bowman's capsule thickening and glomerular size. There was also a shift to larger mesangial area and increased macrophage staining in diabetic WT mice compared with Papp-A KO mice. In summary, elevatedPAPP-A expression in glomeruli is associated with diabetic nephropathy in humans and absence of PAPP-A is associated with resistance to the development of indicators of diabeticnephropathy in mice. These data suggest PAPP-A as a potential therapeutic target for diabetic nephropathy.

AB - We investigated pregnancy-associated plasma protein-A (PAPP-A) in diabetic nephropathy. Normal human kidney showed specific staining for PAPP-A in glomeruli, and this staining was markedly increased in diabetic kidney. To assess the possible contribution of PAPP-A in the development of diabetic nephropathy, we induced diabetes with streptozotocin in14-month-old WT and Papp-A knockout (KO) mice. Renal histopathology was evaluated after 4 months of stable hyperglycemia. Kidneys from diabetic WT mice showed multiple abnormalities including thickening of Bowman's capsule (100% of mice), increased glomerular size (80% of mice), tubule dilation (80% of mice), and mononuclear cell infiltration (90% of mice). Kidneys of age-matched non-diabetic WT mice had similar evidence of tubule dilation and mononuclear cell infiltration to those of diabetic WT mice, indicating that these changes were predominantly age-related. However, thickened Bowman's capsule and increased glomerular size appeared specific for the experimental diabetes. Kidneys from diabetic Papp-A KO mice had significantly reduced or no evidence of changes in Bowman's capsule thickening and glomerular size. There was also a shift to larger mesangial area and increased macrophage staining in diabetic WT mice compared with Papp-A KO mice. In summary, elevatedPAPP-A expression in glomeruli is associated with diabetic nephropathy in humans and absence of PAPP-A is associated with resistance to the development of indicators of diabeticnephropathy in mice. These data suggest PAPP-A as a potential therapeutic target for diabetic nephropathy.

KW - Bowman's capsule

KW - Diabetes

KW - Kidney

KW - Pregnancy-associated plasma protein-A

UR - http://www.scopus.com/inward/record.url?scp=84884187479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884187479&partnerID=8YFLogxK

U2 - 10.1530/JOE-13-0167

DO - 10.1530/JOE-13-0167

M3 - Article

C2 - 23881937

AN - SCOPUS:84884187479

VL - 219

SP - 51

EP - 58

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 1

ER -